| 期 |
栏目 |
标题 |
文件 |
| 卷 78, 编号 6 (2003) |
Editorial |
Ischemic disease of the kidneys |
|
| 卷 78, 编号 3 (2003) |
Editorial |
Legochnyy gistiotsitoz X - sovremennye predstavleniya, diagnostika i taktika lecheniya |
|
| 卷 78, 编号 6 (2003) |
Editorial |
Nephrological aspects of congestivecardiac failure |
|
| 卷 79, 编号 6 (2004) |
Editorial |
Cardiorenai interactions: ciinicai indications and roie in pathogenesis of cardiovascular and renal diseases |
|
| 卷 79, 编号 6 (2004) |
Editorial |
Hyperhomocysteinemia and acute phase proteins in various forms of ischemic heart disease |
|
| 卷 79, 编号 9 (2004) |
Editorial |
Chronic progressive nephropathies and modern lifestyle |
|
| 卷 79, 编号 9 (2004) |
Editorial |
Progressiveazotemia provoked by ACE inhibitor in renal ischemia |
|
| 卷 80, 编号 2 (2008) |
Editorial |
Combination of ace inhibitor with thiaside-like diuretic as an independent strategy of improved prognosis in type 2 diabetes mcllitus. advance trial |
|
| 卷 80, 编号 6 (2008) |
Editorial |
Loop diuretics in the treatment of edema: torasemide potentials |
|
| 卷 80, 编号 6 (2008) |
Editorial |
Resistent arterial hypertension |
|
| 卷 80, 编号 8 (2008) |
Editorial |
Cardiorenal syndrome in ischemic renal disease (atherosclerotic renovascular hypertension) |
|
| 卷 80, 编号 8 (2008) |
Editorial |
Acute renal failure caused by cholesterol embolism of the intrarenal arteries after coronaroangiography: success of glucocorticosteroid treatment |
|
| 卷 81, 编号 3 (2009) |
Editorial |
Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role |
|
| 卷 81, 编号 8 (2009) |
Editorial |
Renin as a target of direct pharmacological block in arterial hypertension |
|
| 卷 85, 编号 6 (2013) |
Editorial |
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases |
|
| 卷 85, 编号 6 (2013) |
Editorial |
Specific features of cognitive impairments in patients with predialysis chronic kidney disease |
|
| 卷 85, 编号 8 (2013) |
Editorial |
Teaching therapeutic disciplines: vectors of modernization |
|
| 卷 85, 编号 6 (2013) |
Editorial |
Phosphate binders in chronic kidney disease: The positions of sevelamer |
|
| 卷 86, 编号 4 (2014) |
Editorial |
Clinical diagnosis progress and continuing medical education |
|
| 卷 86, 编号 1 (2014) |
Editorial |
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease |
|
| 卷 86, 编号 6 (2014) |
Editorial |
Chronic kidney disease and vascular dementia |
|
| 卷 86, 编号 6 (2014) |
Editorial |
Clinical significance of serum and urinary biomarkers for water-salt metabolism in patients with proteinuric forms of chronic glomerulonephritis |
|
| 卷 86, 编号 8 (2014) |
Editorial |
Interstitial pulmonary fibrosis: The role of angiogenic factors, the inhibitory pathways of progression |
|
| 卷 86, 编号 10 (2014) |
Editorial |
Effect of erythropoietin and its combination with hypoxic altitude chamber training on the clinical and functional manifestations of chronic glomerulonephritis |
|
| 卷 86, 编号 12-2 (2014) |
Editorial |
Morphological verification of renal lesion as a compulsory stage in the diagnosis of Fabry disease |
|
| 卷 86, 编号 12-2 (2014) |
Editorial |
Giant cell arteritis as a cause of fever of unclear genesis in the elderly |
|
| 卷 86, 编号 10 (2014) |
Editorial |
Full-dose combinations of antihypertensive drugs: What has changed in experts' guidelines? |
|
| 卷 87, 编号 4 (2015) |
Editorial |
Better diagnosis is an obligatory condition for improving medical care quality |
|
| 卷 87, 编号 3 (2015) |
Editorial |
Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Acute glomerulonephritis in the 21st century |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease |
|
| 卷 88, 编号 6 (2016) |
Editorial |
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum |
(Rus)
|
| 卷 88, 编号 4 (2016) |
Editorial |
Myocardial injury associated with chronic hepatitis C: Clinical types and pathogenetic components |
(Rus)
|
| 卷 88, 编号 6 (2016) |
Editorial |
Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs |
(Rus)
|
| 卷 88, 编号 9 (2016) |
Editorial |
Occupational factors and a risk of cardiovascular diseases |
(Rus)
|
| 卷 89, 编号 4 (2017) |
Editorial |
Direct oral anticoagulants in atrial fibrillation patients aged 75 years or older: Efficacy and safety balance |
(Rus)
|
| 卷 89, 编号 12 (2017) |
Editorial |
The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice |
(Rus)
|
| 卷 89, 编号 12 (2017) |
Editorial |
Anticoagulant therapy in patients with atrial fibrillation and reduced kidney function of diabetic and non-diabetic etiologies |
(Rus)
|
| 卷 89, 编号 8 (2017) |
Editorial |
Giant cell arteritis: Genetic and epigenetic aspects |
(Rus)
|
| 卷 89, 编号 10 (2017) |
Editorial |
Endothelial dysfunction and arterial wall stiffness: New targets in diabetic nephropathy |
(Rus)
|
| 卷 89, 编号 8 (2017) |
Editorial |
Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation |
(Rus)
|
| 卷 91, 编号 12 (2019) |
Editorial |
Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice |
(Rus)
|
